Cited by 134Radiomics and Machine Learning in Medical ImagingLung Cancer Diagnosis and TreatmentInflammatory Biomarkers in Disease Prognosis

The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.

CT derived radiomic score for predicting the added benefit of adjuvant chemotherapy following surgery in stage I, II resectable non-small cell lung cancer: a retrospective multicohort study for outcome prediction

Open access

Vaidya, Pranjal, Bera, Kaustav, Gupta, Amit, Wang, Xiangxue, Corredor, Germán, Fu, Pingfu, Beig, Niha, Prasanna, Prateek, Patil, Pradnya D, Velu, Priya D, Rajiah, Prabhakar, Gilkeson, Robert, Feldman, Michael D, Choi, Humberto, Velcheti, Vamsidhar, Madabhushi, Anant·2020·The Lancet Digital Health

DOI 10.1016/s2589-7500(20)30002-9PMC PMC7051021

Open this paper in CoChat — free account Open PDF

Abstract

Background Use of adjuvant chemotherapy in patients with early-stage lung cancer is controversial because no definite biomarker exists to identify patients who would receive added benefit from it. We aimed to develop and validate a quantitative radiomic risk score (QuRiS) and associated nomogram (QuRNom) for early-stage non-small cell lung cancer (NSCLC) that is prognostic of disease-free survival and predictive of the added benefit of adjuvant chemotherapy following surgery. Methods We did a retrospective multicohort study of individuals with early-stage NSCLC (stage I and II) who either received surgery alone or surgery plus adjuvant chemotherapy. We selected patients for whom we had available pre-treatment diagnostic CT scans and corresponding survival information. We used radiomic texture features derived from within and outside the primary lung nodule on chest CT scans of patients from the Cleveland Clinic Foundation (Cleveland, OH, USA; cohort D 1 ) to develop QuRiS. A least absolute shrinkage and selection operator-Cox regularisation model was used for data dimension reduction, feature selection, and QuRiS construction. QuRiS was independently validated on a cohort of patients from the University of Pennsylvania (Philadephia, PA, USA; cohort D 2 ) and a cohort of patients whose CT scans were derived from The Cancer Imaging Archive (cohort D 3 ). QuRNom was constructed by integrating QuRiS with tumour and node descriptors (according to the tumour, node, metastasis staging system) and lymphovascular invasion. The primary endpoint of the study was the assessment of the performance of QuRiS and QuRNom in predicting disease-free survival. The added benefit of adjuvant chemotherapy estimated using QuRiS and QuRNom was validated by comparing patients who received adjuvant chemotherapy versus patients who underwent surgery alone in cohorts D 1 –D 3 . Findings We included: 329 patients in cohort D 1 (73 [22%] had surgery plus adjuvant chemotherapy and 256 (78%) had surgery alone); 114 patients in cohort D 2 (33 [29%] had surgery plus adjuvant chemotherapy and 81 (71%) had surgery alone); and 82 patients in cohort D 3 (24 [29%] had surgery plus adjuvant chemotherapy and 58 (71%) had surgery alone). QuRiS comprised three intratumoral and 10 peritumoral CT-radiomic features and was found to be significantly associated with disease-free survival (ie, prognostic validation of QuRiS; hazard ratio for predicted high-risk vs predicted low-risk groups 1·56, 95% CI 1·08–2·23, p=0·016 for cohort D 1 ; 2·66, 1·24–5·68, p=0·011 for cohort D 2 ; and 2·67, 1·39–5·11, p=0·0029 for cohort D 3 ). To validate the predictive performance of QuRiS, patients were partitioned into three risk groups (high, intermediate, and low risk) on the basis of their corresponding QuRiS. Patients in the high-risk group were observed to have significantly longer survival with adjuvant chemotherapy than patients who underwent surgery alone (0·27, 0·08–0·95, p=0·042, for cohort D 1 ; 0·08, 0·01–0·42, p=0·0029, for cohorts D 2 and D 3 combined). As concerns QuRNom, the nomogram-estimated survival benefit was predictive of the actual efficacy of adjuvant chemotherapy (0·25, 0·12–0·55, p<0·0001, for cohort D 1 ; 0·13, <0·01–0·99, p=0·0019 for cohort D 3 ). Interpretation QuRiS and QuRNom were validated as being prognostic of disease-free survival and predictive of the added benefit of adjuvant chemotherapy, especially in clinically defined low-risk groups. Since QuRiS is based on routine chest CT imaging, with additional multisite independent validation it could potentially be employed for decision management in non-invasive treatment of resectable lung cancer. Funding National Cancer Institute of the US National Institutes of Health, National Center for Research Resources, US Department of Veterans Affairs Biomedical Laboratory Research and Development Service, Department of Defence, National Institute of Diabetes and Digestive and Kidney Diseases, Wallace H Coulter Foundation, Case Western Reserve University, and Dana Foundation.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/s2589-7500(20)30002-9

Cites

27 of 27 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Radiomics: Images Are More than Pictures, They Are Data
Gillies, R. J., Kinahan, P. E., & Hricak, H. (2016) · Radiology · doi:10.1148/radiol.2015151169 · Cited by 8,421
The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer
Goldstraw, P. G., Chansky, K., Crowley, J. J., Rami–Porta, R., Asamura, H., Eberhardt, W., Nicholson, A. G., Groome, P. A., Mitchell, A., Bolejack, V., et al. (2016) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2015.09.009 · Cited by 4,616
Nomograms in oncology: more than meets the eye
Balachandran, V. P., Gönen, M., Smith, J. J., & DeMatteo, R. P. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(14)71116-7 · Cited by 3,294
Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group.
Pignon, J.-P., Tribodet, H., Scagliotti, G. V., Douillard, J.-Y., Shepherd, F. A., Stephens, R. J., Dunant, A., Torri, V., Rosell, R., Seymour, L., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.13.9030 · Cited by 2,642
Cisplatin-Based Adjuvant Chemotherapy in Patients with Completely Resected Non–Small-Cell Lung Cancer
The International Adjuvant Lung Cancer Trial Collaborative Group (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031644 · Cited by 2,334
Vinorelbine plus Cisplatin vs. Observation in Resected Non–Small-Cell Lung Cancer
Winton, T. L., Livingston, R. B., Johnson, D. H., Rigas, J. R., Johnston, M., Butts, C. A., Cormier, Y. F., Goss, G., Inculet, R., Vallières, E., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043623 · Cited by 1,810
Adjuvant Paclitaxel Plus Carboplatin Compared With Observation in Stage IB Non–Small-Cell Lung Cancer: CALGB 9633 With the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups
Strauss, G. M., Herndon, J. E., Maddaus, M. A., Johnstone, D. W., Johnson, E. A., Harpole, D. H., Gillenwater, H. H., Watson, D. M., Sugarbaker, D. J., Schilsky, R. L., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.16.4855 · Cited by 973
Radiomics Signature: A Potential Biomarker for the Prediction of Disease-Free Survival in Early-Stage (I or II) Non—Small Cell Lung Cancer
Huang, Y., Liu, Z., He, L., Chen, X., Pan, D., Ma, Z., Liang, C., Tian, J., & Liang, C. (2016) · Radiology · doi:10.1148/radiol.2016152234 · Cited by 753
Randomized Study of Adjuvant Chemotherapy for Completely Resected Stage I, II, or IIIA Non-Small-Cell Lung Cancer
Scagliotti, G. V. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djg059 · Cited by 593
Deep learning for lung cancer prognostication: A retrospective multi-cohort radiomics study
Hosny, A., Parmar, C., Coroller, T. P., Grossmann, P., Zeleznik, R., Kumar, A., Bussink, J., Gillies, R. J., Mak, R. H., & Aerts, H. J. W. L. (2018) · PLOS Medicine · doi:10.1371/journal.pmed.1002711 · Cited by 579

Show all 27 references

Sorted by citations

Predicting cancer outcomes with radiomics and artificial intelligence in radiology
Bera, K., Braman, N., Gupta, A., Velcheti, V., & Madabhushi, A. (2022) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-021-00560-7 · Cited by 819
Self-citation
Revisiting neoadjuvant therapy in non-small-cell lung cancer
Saw, S. P. L., Ong, B., Chua, K. L. M., Takano, A. M., & Tan, D. S. W. (2021) · The Lancet Oncology · doi:10.1016/s1470-2045(21)00383-1 · Cited by 216
Harnessing non-destructive 3D pathology
Liu, J. T. C., Glaser, A. K., Bera, K., True, L. D., Reder, N. P., Eliceiri, K. W., & Madabhushi, A. (2021) · Nature Biomedical Engineering · doi:10.1038/s41551-020-00681-x · Cited by 160
Self-citation
Navigating the landscape of multimodal AI in medicine: A scoping review on technical challenges and clinical applications
Schouten, D., Nicoletti, G., Dille, B., Chia, C., Vendittelli, P., Schuurmans, M., Litjens, G., & Khalili, N. (2025) · Medical Image Analysis · doi:10.1016/j.media.2025.103621 · Cited by 162
Radiomics and artificial intelligence in lung cancer screening
Binczyk, F., Prazuch, W., Bozek, P., & Polańska, J. (2021) · Translational Lung Cancer Research · doi:10.21037/tlcr-20-708 · Cited by 150
Introduction to radiomics for a clinical audience
McCague, C., Ramlee, S., Reinius, M., SELBY, I. A., Hulse, D., Piyatissa, P., Bura, V., Crispin‐Ortuzar, M., Sala, E., & Woitek, R. (2023) · Clinical Radiology · doi:10.1016/j.crad.2022.08.149 · Cited by 137
Application of radiomics-based multiomics combinations in the tumor microenvironment and cancer prognosis
Kang, W., Qiu, X., Luo, Y., Luo, J., Liu, Y., Xi, J., Li, X., & Yang, Z. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04437-4 · Cited by 127
Non-invasive tumor microenvironment evaluation and treatment response prediction in gastric cancer using deep learning radiomics
Jiang, Y., Zhou, K., Sun, Z., Wang, H., Xie, J., Zhang, T., Sang, S., Islam, M. T., Wang, J.-Y., Chen, C., et al. (2023) · Cell Reports Medicine · doi:10.1016/j.xcrm.2023.101146 · Cited by 120
Novel, non-invasive imaging approach to identify patients with advanced non-small cell lung cancer at risk of hyperprogressive disease with immune checkpoint blockade
Vaidya, P., Bera, K., Patil, P., Gupta, A., Jain, P., Alilou, M., Khorrami, M., Velcheti, V., & Madabhushi, A. (2020) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2020-001343 · Cited by 98
Self-citation
On the performance of lung nodule detection, segmentation and classification
Gu, D., Liu, G., & Xue, Z. (2021) · Computerized Medical Imaging and Graphics · doi:10.1016/j.compmedimag.2021.101886 · Cited by 116
Biology-guided deep learning predicts prognosis and cancer immunotherapy response
Jiang, Y., Zhang, Z., Wang, W., Huang, W., Chen, C., Xi, S., Ahmad, M. U., Ren, Y., Sang, S., Xie, J., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-40890-x · Cited by 122
Enhancing NSCLC recurrence prediction with PET/CT habitat imaging, ctDNA, and integrative radiogenomics-blood insights
Sujit, S. J., Aminu, M., Karpinets, T. V., Chen, P., Saad, M. B., Salehjahromi, M., Boom, J. D., Qayati, M., George, J. M., Allen, H., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-47512-0 · Cited by 109
ITHscore: comprehensive quantification of intra-tumor heterogeneity in NSCLC by multi-scale radiomic features
Li, J., Qiu, Z., Zhang, C., Chen, S., Wang, M.-M., Meng, Q., Lu, H., Wei, L., Lv, H., Zhong, W., et al. (2022) · European Radiology · doi:10.1007/s00330-022-09055-0 · Cited by 109
Radiological tumour classification across imaging modality and histology
Wu, J., Li, C., Gensheimer, M. F., Padda, S. K., Kato, F., Shirato, H., Wei, Y., Schönlieb, C., Price, S. J., Jaffray, D. A., et al. (2021) · Nature Machine Intelligence · doi:10.1038/s42256-021-00377-0 · Cited by 98
Computed tomography-based radiomics decodes prognostic and molecular differences in interstitial lung disease related to systemic sclerosis
Gote-Schniering, J., Maciukiewicz, M., Gabryś, H. S., Brunner, M., Blüthgen, C., Meier, C., Braga-Lagache, S., Uldry, A., Heller, M., Distler, O., et al. (2021) · European Respiratory Journal · doi:10.1183/13993003.04503-2020 · Cited by 97
Immunotherapy in non-small cell lung cancer: Past, present, and future directions
Punekar, S. R., Shum, E., Grello, C., Lau, S. C. M., & Velcheti, V. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.877594 · Cited by 89
Self-citation
Feature selection methods and predictive models in CT lung cancer radiomics
Ge, G. R., & Zhang, J. (2022) · Journal of Applied Clinical Medical Physics · doi:10.1002/acm2.13869 · Cited by 77
Integrating pathomics with radiomics and genomics for cancer prognosis: A brief review
Lu, C. Y., Shiradkar, R., & Liu, Z. (2021) · Chinese Journal of Cancer Research · doi:10.21147/j.issn.1000-9604.2021.05.03 · Cited by 71
Can quantitative peritumoral CT radiomics features predict the prognosis of patients with non-small cell lung cancer? A systematic review
Wu, L., Lou, X., Kong, N., Xu, M., & Gao, C. (2022) · European Radiology · doi:10.1007/s00330-022-09174-8 · Cited by 69
The Application of Artificial Intelligence in the Diagnosis and Drug Resistance Prediction of Pulmonary Tuberculosis
Liang, S., Ma, J., Wang, G., Shao, J., Li, J., Deng, H., Wang, C., & Li, W. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.935080 · Cited by 66
Radiographical assessment of tumour stroma and treatment outcomes using deep learning: a retrospective, multicohort study
Jiang, Y., Liang, X., Han, Z., Wang, W., Xi, S., Li, T., Chen, C., Yuan, Q., Li, N., Yu, J., et al. (2021) · The Lancet Digital Health · doi:10.1016/s2589-7500(21)00065-0 · Cited by 58
Deep learning in radiology for lung cancer diagnostics: A systematic review of classification, segmentation, and predictive modeling techniques
Atmakuru, A., Chakraborty, S., Faust, O., Salvi, M., Barua, P. D., Molinari, F., Acharya, U. R., & Homaira, N. (2024) · Expert Systems with Applications · doi:10.1016/j.eswa.2024.124665 · Cited by 62
What is Artificial Intelligence Surgery?
Gumbs, A. A., Perretta, S., Dallemagne, B., & Chouillard, E. K. (2021) · Artificial Intelligence Surgery · doi:10.20517/ais.2021.01 · Cited by 53
Phantom-based radiomics feature test–retest stability analysis on photon-counting detector CT
Hertel, A., Tharmaseelan, H., Rotkopf, L. T., Nörenberg, D., Riffel, P., Nikolaou, K., Weiß, J., Bamberg, F., Schoenberg, S. O., Froelich, M. F., et al. (2023) · European Radiology · doi:10.1007/s00330-023-09460-z · Cited by 52
Radiomics for Predicting Lung Cancer Outcomes Following Radiotherapy: A Systematic Review
Walls, G., Osman, S. O. S., Brown, K. H., Butterworth, K. T., Hanna, G. G., Hounsell, A. R., McGarry, C. K., Leijenaar, R. T. H., Lambin, P., Cole, A., et al. (2021) · Clinical Oncology · doi:10.1016/j.clon.2021.10.006 · Cited by 53
Image analysis reveals molecularly distinct patterns of TILs in NSCLC associated with treatment outcome
Ding, R., Prasanna, P., Corredor, G., Barrera, C., Zens, P., Lu, C. Y., Velu, P., Leo, P., Beig, N. G., Li, H., et al. (2022) · npj Precision Oncology · doi:10.1038/s41698-022-00277-5 · Cited by 50
Self-citation
Molecular biomarkers in early stage lung cancer
Rodríguez, M. F., Ajona, D., Seijo, L. M., Sanz‐Ortega, J., Valencia, K., Corral, J., Mesa, M., Pı́o, R., Calvo, A., Lozano, M. D., et al. (2021) · Translational Lung Cancer Research · doi:10.21037/tlcr-20-750 · Cited by 48
Radiological artificial intelligence - predicting personalized immunotherapy outcomes in lung cancer
Roisman, L. C., Kian, W., Anoze, A., Fuchs, V., Spector, M., Steiner, R., Kassel, L., Rechnitzer, G., Fried, I., Peled, N., et al. (2023) · npj Precision Oncology · doi:10.1038/s41698-023-00473-x · Cited by 43
From Images to Genes: Radiogenomics Based on Artificial Intelligence to Achieve Non‐Invasive Precision Medicine in Cancer Patients
Guo, Y., Li, T., Gong, B., Hu, Y., Wang, S., Yang, L., & Zheng, C. (2024) · Advanced Science · doi:10.1002/advs.202408069 · Cited by 49
Challenges and perspectives in use of artificial intelligence to support treatment recommendations in clinical oncology
Duwe, G., Mercier, D., Wiesmann, C., Kauth, V., Moench, K., Junker, M., Neumann, C., Haferkamp, A., Dengel, A., & Höfner, T. (2024) · Cancer Medicine · doi:10.1002/cam4.7398 · Cited by 35
Virtual Monoenergetic Images of Dual-Energy CT—Impact on Repeatability, Reproducibility, and Classification in Radiomics
Euler, A., Laqua, F. C., Cester, D., Lohaus, N., Sartoretti, T., dos Santos, D. P., Alkadhi, H., & Baeßler, B. (2021) · Cancers · doi:10.3390/cancers13184710 · Cited by 30
A Clinical-Radiomics Nomogram Based on Computed Tomography for Predicting Risk of Local Recurrence After Radiotherapy in Nasopharyngeal Carcinoma
Zhu, C., Huang, H., Liu, X., Chen, H., Jiang, H., Liao, C., Pang, Q., Dang, J., Liu, P., & Lu, H. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.637687 · Cited by 28
Multicenter radio-multiomic analysis for predicting breast cancer outcome and unravelling imaging-biological connection
You, C., Su, G.-H., Zhang, X., Xiao, Y., Zheng, R., Sun, S., Zhou, J.-Y., Lin, L., Wang, Z., Wang, H., et al. (2024) · npj Precision Oncology · doi:10.1038/s41698-024-00666-y · Cited by 27
Multimodal radiopathological integration for prognosis and prediction of adjuvant chemotherapy benefit in resectable lung adenocarcinoma: A multicentre study
Lin, H., Hua, J., Gong, Z., Chen, M., Qiu, B., Wu, Y., He, W., Wang, Y., Feng, Z., Liang, Y., et al. (2025) · Cancer Letters · doi:10.1016/j.canlet.2025.217557 · Cited by 30
Self-citation
Clinical Artificial Intelligence Applications in Radiology
Lee, S., & Summers, R. M. (2021) · Radiologic Clinics of North America · doi:10.1016/j.rcl.2021.07.001 · Cited by 24
Photon-counting detector CT-based virtual monoenergetic reconstructions: repeatability and reproducibility of radiomics features of an organic phantom and human myocardium
Wolf, E. V., Müller, L., Schoepf, U. J., Fink, N., Griffith, J. P., Zsarnóczay, E., Baruah, D., Suranyi, P. S., Kabakus, I. M., Halfmann, M. C., et al. (2023) · European Radiology Experimental · doi:10.1186/s41747-023-00371-8 · Cited by 24
CT Radiomic Features for Predicting Resectability and TNM Staging in Thymic Epithelial Tumors
Araújo-Filho, J. D. A. B., Mayoral, M., Zheng, J., Tan, K. S., Gibbs, P., Shepherd, A. F., Rimner, A., Simone, C. B., Riely, G. J., Huang, J. G., et al. (2021) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2021.03.084 · Cited by 24
Radiomics analysis of ultrasonic image predicts sensitive effects of microwave ablation in treatment of patient with benign breast tumors
Li, G., An, C., Yu, J., & Huang, Q. (2022) · Biomedical Signal Processing and Control · doi:10.1016/j.bspc.2022.103722 · Cited by 23
A Novel Feature Engineering Method Based on Latent Representation Learning for Radiomics: Application in NSCLC Subtype Classification
Song, F., Tian, J., Zhang, P., Ma, C., Sun, Y., Feng, Y., Zhang, T., Lei, Y., He, Y., Cai, Z., et al. (2023) · IEEE Journal of Biomedical and Health Informatics · doi:10.1109/jbhi.2023.3290006 · Cited by 22
Radiomics model based on intratumoral and peritumoral features for predicting major pathological response in non-small cell lung cancer receiving neoadjuvant immunochemotherapy
Huang, D., Chen, L., Jiang, Y., Xin, E., Xu, F., Gan, Y., Xu, R., Wang, F., Zhang, H., Lou, K., et al. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1348678 · Cited by 24
Artificial Intelligence in Lung Imaging
Choe, J., Lee, S. M., Hwang, H. J., Lee, S. M., Yun, J., Kim, N., & Seo, J. B. (2022) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0042-1755571 · Cited by 21
Predicting lymph node metastasis in papillary thyroid carcinoma: radiomics using two types of ultrasound elastography
Zhang, X., Zhang, D., Zhou, W., Wang, Z., Zhang, C., Li, J., Wang, L., & Cui, X. (2025) · Cancer Imaging · doi:10.1186/s40644-025-00832-w · Cited by 20
Prognostic and predictive values of a multimodal nomogram incorporating tumor and peritumor morphology with immune status in resectable lung adenocarcinoma
Lin, H., Hua, J., Wang, Y., Chen, M., Liang, Y., Yan, L., Zhao, W., Luo, S., Hong, D., Chen, X., et al. (2025) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2024-010723 · Cited by 25
Radiomics for lung cancer diagnosis, management, and future prospects
Martell, M. B., Linton‐Reid, K., Chen, M., & Aboagye, E. O. (2025) · Clinical Radiology · doi:10.1016/j.crad.2025.106926 · Cited by 23
Assessing the robustness of radiomics/deep learning approach in the identification of efficacy of anti–PD-1 treatment in advanced or metastatic non-small cell lung carcinoma patients
Ren, Q., Xiong, F., Zhu, P., Chang, X., Wang, G., He, N., & Jin, Q. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.952749 · Cited by 20
Local control strategies for management of NSCLC with oligoprogressive disease
Mavrikios, A., Remón, J., Quevrin, C., Mercier, O. M., Tselikas, L., Botticella, A., Nicolas, E., Deutsch, É., Besse, B., Planchard, D., et al. (2023) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2023.102621 · Cited by 19
Reimagining T Staging Through Artificial Intelligence and Machine Learning Image Processing Approaches in Digital Pathology
Bera, K., Katz, I. A., & Madabhushi, A. (2020) · JCO Clinical Cancer Informatics · doi:10.1200/cci.20.00110 · Cited by 20
Self-citation
Computationally integrating radiology and pathology image features for predicting treatment benefit and outcome in lung cancer
Vaidya, P., Khorrami, M., Bera, K., Fu, P., Delasos, L., Gupta, A. B., Barrera, C., Pennell, N. A., Velcheti, V., & Madabhushi, A. (2025) · npj Precision Oncology · doi:10.1038/s41698-025-00939-0 · Cited by 20
Self-citation
Could the underlying biological basis of prognostic radiomics and deep learning signatures be explored in patients with lung cancer? A systematic review
Qian, L.-J., Wu, T., Kong, S., Lou, X., Jiang, Y., Tan, Z., Wu, L., & Gao, C. (2024) · European Journal of Radiology · doi:10.1016/j.ejrad.2024.111314 · Cited by 18
MRI radiomics in overall survival prediction of local advanced cervical cancer patients tread by adjuvant chemotherapy following concurrent chemoradiotherapy or concurrent chemoradiotherapy alone
Wei, G., Jiang, P., Tang, Z., Qu, A., Deng, X., Guo, F., Sun, H., Zhang, Y., Gu, L., Zhang, S., et al. (2022) · Magnetic Resonance Imaging · doi:10.1016/j.mri.2022.05.019 · Cited by 18
Computed tomography radiomic features hold prognostic utility for canine lung tumors: An analytical study
Able, H., Wolf-Ringwall, A. L., Rendahl, A., Ober, C. P., Seelig, D. M., Wilke, C. T., & Lawrence, J. (2021) · PLoS ONE · doi:10.1371/journal.pone.0256139 · Cited by 17
Machine Learning in Lung Cancer Radiomics
Li, J., Li, Z., Wei, L., & Zhang, X. (2023) · Machine Intelligence Research · doi:10.1007/s11633-022-1364-x · Cited by 17
Prediction of Two-Year Recurrence-Free Survival in Operable NSCLC Patients Using Radiomic Features from Intra- and Size-Variant Peri-Tumoral Regions on Chest CT Images
Lee, S., Jung, J., Hong, H., & Kim, B.-S. (2022) · Diagnostics · doi:10.3390/diagnostics12061313 · Cited by 16
Clinical Significance of a Circulating Tumor Cell-based Classifier in Stage IB Lung Adenocarcinoma
Ren, L., Zhong, X., Liu, W., Xu, D., Lei, Y., Zhou, J., Jiang, W., He, Q., Sun, Y., & Ke, Z. (2021) · Annals of Surgery · doi:10.1097/sla.0000000000004780 · Cited by 15
A new magnetic resonance imaging tumour response grading scheme for locally advanced rectal cancer
Pang, X., Xie, P., Li, Y., Chen, H., Zheng, J., Meng, X., & Wan, X. (2022) · British Journal of Cancer · doi:10.1038/s41416-022-01801-x · Cited by 14
Prediction of Radiation-Induced Hypothyroidism Using Radiomic Data Analysis Does Not Show Superiority over Standard Normal Tissue Complication Models
Smyczyńska, U., Grabia, S., Nowicka, Z., Papis-Ubych, A., Bibik, R., Latusek, T., Rutkowski, T., Fijuth, J., Fendler, W., & Tomasik, B. (2021) · medRxiv · doi:10.3390/cancers13215584 · Cited by 8
The International Radiomics Platform – An Initiative of the German and Austrian Radiological Societies – First Application Examples
Overhoff, D., Kohlmann, P., Frydrychowicz, A. P., Gatidis, S., Loewe, C., Moltz, J. H., Kuhnigk, J., Gutberlet, M., Winter, H., Völker, M., et al. (2020) · RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren · doi:10.1055/a-1244-2775 · Cited by 12
Development and Validation of a DeepSurv Nomogram to Predict Survival Outcomes and Guide Personalized Adjuvant Chemotherapy in Non-Small Cell Lung Cancer
Yang, B., Liu, C., Wu, R., Zhong, J., Li, A., Ma, L., Zhong, J., Yin, S., Zhou, C., Ge, Y., et al. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.895014 · Cited by 16
Identification of pulmonary adenocarcinoma and benign lesions in isolated solid lung nodules based on a nomogram of intranodal and perinodal CT radiomic features
Yi, L., Peng, Z., Chen, Z., Tao, Y., Lin, Z., He, A., Jin, M., Peng, Y., Zhong, Y., Yan, H., et al. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.924055 · Cited by 11
Improving prognosis and assessing adjuvant chemotherapy benefit in locally advanced rectal cancer with deep learning for MRI: A retrospective, multi-cohort study
Zhang, S., Cai, G., Xie, P., Sun, C., Li, B., Dai, W., Liu, X., Qiu, Q., Du, Y., Li, Z., et al. (2023) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2023.109899 · Cited by 10
Preoperative computed tomography-based tumoral radiomic features prediction for overall survival in resectable non-small cell lung cancer
Peng, B., Wang, K., Xu, R., Guo, C., Lu, T., Li, Y., Wang, Y., Wang, C., Chang, X., Shen, Z., et al. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1131816 · Cited by 10
The future of radiomics in lung cancer
Thawani, R., & Mustafa, S. (2020) · The Lancet Digital Health · doi:10.1016/s2589-7500(20)30022-4 · Cited by 10
Beyond DNA-targeting in Cancer Chemotherapy. Emerging Frontiers - A Review
Mbugua, S. N., Njenga, L. W., Odhiambo, R. A., Wandiga, S. O., & Onani, M. O. (2020) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026620666200819160213 · Cited by 11
A Multi-Classification Model for Predicting the Invasiveness of Lung Adenocarcinoma Presenting as Pure Ground-Glass Nodules
Song, F., Song, L., Xing, T., Feng, Y., Song, X., Zhang, P., Zhang, T., Zhu, Z., Song, W., & Zhang, G. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.800811 · Cited by 10
Multiparameter spectral CT-based radiomics in predicting the expression of programmed death ligand 1 in non-small-cell lung cancer
Zheng, X. X., Ma, Y. Q., Cui, Y. Q., Dong, S., Chang, F. X., Zhu, D. L., & Huang, G. (2024) · Clinical Radiology · doi:10.1016/j.crad.2024.01.006 · Cited by 9
Validation of a radiomic approach to decipher NSCLC immune microenvironment in surgically resected patients
Trentini, F., Mazzaschi, G., Milanese, G., Pavone, C., Madeddu, D., Gnetti, L., Frati, C., Lorusso, B., Lagrasta, C., Minari, R., et al. (2021) · Tumori · doi:10.1177/03008916211000808 · Cited by 8
Non-invasive CT based multiregional radiomics for predicting pathologic complete response to preoperative neoadjuvant chemoimmunotherapy in non-small cell lung cancer
Fan, S., Xie, J., Zheng, S., Wang, J., Zhang, B., Zhang, Z., Wang, S., Cui, Y., Liu, J., Zheng, X., et al. (2025) · European Journal of Radiology · doi:10.1016/j.ejrad.2025.112171 · Cited by 8
Causal AI-based clinical and radiomic analysis for optimizing patient selection in combined immunotherapy and SABR in early-stage NSCLC: a secondary analysis of the phase II I-SABR trial
Saad, M. B., Showkatian, E., Verma, V., Al-Tashi, Q., Aminu, M., Xu, X., Qayati, M., Salehjahromi, M., Sujit, S. J., Kitsel, Y., et al. (2025) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2025-013074 · Cited by 8
Current status and quality of prognosis prediction models of non-small cell lung cancer constructed using computed tomography (CT)-based radiomics: a systematic review and radiomics quality score 2.0 assessment
Jia, X., Wang, Y., Zhang, H., & Sun, D. (2024) · Quantitative Imaging in Medicine and Surgery · doi:10.21037/qims-24-22 · Cited by 8
Markers of Immune Cell Exhaustion as Predictor of Survival in Surgically-Treated Early-Stage NSCLC
Sellmer, L., Kovács, J., Walter, J., Kumbrink, J., Neumann, J. H. L., Kauffmann-Guerrero, D. E., Kiefl, R., Schneider, C., Jung, A., Behr, J., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.858212 · Cited by 8
A Focus on the Synergy of Radiomics and RNA Sequencing in Breast Cancer
Bellini, D., Milan, M., Bordin, A., Rizzi, R., Rengo, M., Vicini, S., Onori, A., Carbone, I., & FALCO, E. D. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24087214 · Cited by 8
Preoperative CT-based radiomic prognostic index to predict the benefit of postoperative radiotherapy in patients with non-small cell lung cancer: a multicenter study
Ma, Z., Men, Y., Liu, Y., Bao, Y., Liu, Q., Yang, X., Wang, J., Deng, L., Zhai, Y., Bi, N., et al. (2024) · Cancer Imaging · doi:10.1186/s40644-024-00707-6 · Cited by 7
PSbBO-Net: A Hybrid Particle Swarm and Bayesian Optimization-based DenseNet for Lung Cancer Detection using Histopathological and CT Images
Raghuvanshi, S. S., Arya, K. V., & Patel, V. (2024) · International Journal of Electrical and Electronics Research · doi:10.37391/ijeer.120343 · Cited by 7
Combined Radiomic and Visual Assessment for Improved Detection of Lung Adenocarcinoma Invasiveness on Computed Tomography Scans: A Multi-Institutional Study
Vaidya, P., Bera, K., Linden, P. A., Gupta, A. B., Rajiah, P. S., Jones, D. R., Bott, M. J., Pass, H. I., Gilkeson, R., Jacono, F. J., et al. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.902056 · Cited by 7
Self-citation
The influence of image selection and segmentation on the extraction of lung cancer imaging radiomics features using 3D-Slicer software
Liu, C., He, Y., & Luo, J. (2025) · BMC Cancer · doi:10.1186/s12885-025-14094-z · Cited by 6
Machine Learning and Computed Tomography Radiomics to Predict Disease Progression to Upfront Pembrolizumab Monotherapy in Advanced Non-Small-Cell Lung Cancer: A Pilot Study
Janzen, I., Ho, C., Melosky, B., Ye, Q.-W., Li, J. L., Wang, G., Lam, S., MacAulay, C., & Yuan, R. (2024) · Cancers · doi:10.3390/cancers17010058 · Cited by 7
Predicting Chemo-Radiotherapy Sensitivity With Concordant Survival Benefit in Non-Small Cell Lung Cancer via Computed Tomography Derived Radiomic Features
Liu, Y., Qi, H., Wang, C., Deng, J., Tan, Y., Lin, L., Cui, Z., Li, J., & Qi, L. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.832343 · Cited by 6
The value of intratumoral and peritumoral radiomics features in differentiating early-stage lung invasive adenocarcinoma (≤3 cm) subtypes
Zhou, T., Yang, M., Xiong, W., Zhu, F., Li, Q., Li, Z., & Zhao, Z. (2024) · Translational Cancer Research · doi:10.21037/tcr-23-1324 · Cited by 6
Bibliometrics research on radiomics of lung cancer
Liang, H., Chen, Z., Wei, F., Yang, R.-H., & Zhou, H. (2021) · Translational Cancer Research · doi:10.21037/tcr-21-1277 · Cited by 6
Evaluating peritumoral and intratumoral radiomics signatures for predicting lymph node metastasis in surgically resectable non-small cell lung cancer
Xu, R., Wang, K., Peng, B., Zhou, X., Wang, C., Lu, T., Shi, J., Zhao, J., & Zhang, L. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1427743 · Cited by 5
A prognostic index integrating deep learning baseline PET/CT biomarkers and multi-omics profiling in diffuse large B cell lymphoma
Wang, Y., Wang, X., Huang, X.-Y., Jing, H., Jiang, S., Li, H., Mu, R.-J., Shi, Q., Fu, D., Li, Z., et al. (2025) · Cell Reports Medicine · doi:10.1016/j.xcrm.2025.102452 · Cited by 6
Self-citation
Radiomics in surgical oncology: applications and challenges
Williams, T. L., Saadat, L. V., Gönen, M., Wei, A. C.-C., Gian, R. K., & Simpson, A. L. (2021) · Computer Assisted Surgery · doi:10.1080/24699322.2021.1994014 · Cited by 5
Identifying 18F-FDG PET-metabolic radiomic signature for lung adenocarcinoma prognosis via the leveraging of prognostic transcriptomic module
Li, J., Liu, Y., Dong, W., Zhou, Y., Jing-quan, W., Luan, K., & Qi, L. (2021) · Quantitative Imaging in Medicine and Surgery · doi:10.21037/qims-21-706 · Cited by 5
Assessing the reproducibility, stability, and biological interpretability of multimodal computed tomography image features for prognosis in advanced non‐small cell lung cancer
Wang, J., Dai, G., Ren, X., Shi, R., Luo, R., Liu, J., Deng, K., & Song, J. (2024) · iRadiology · doi:10.1002/ird3.56 · Cited by 4
Photon-Counting CT Scan Phantom Study: Stability of Radiomics Features
Dawi, L., Amouzouga, K., Muller, S. L., Nallet, C., Dupont, A. M., Vielliard, B., Croisille, C., Moussier, A., Garcia, G. C. T. E., Bidault, F., et al. (2025) · Diagnostics · doi:10.3390/diagnostics15060649 · Cited by 4
Association of postoperative recurrence with radiological and clinicopathological features in patients with stage IA–IIA lung adenocarcinoma
Zhang, Y., Zhao, F., Wu, M., Zhao, Y., Liu, Y., Li, Q., Zhou, G., & Ye, Z. (2021) · European Journal of Radiology · doi:10.1016/j.ejrad.2021.109802 · Cited by 4
Cancer Stem Cells and Cell Cycle Genes as Independent Predictors of Relapse in Non-small Cell Lung Cancer: Secondary Analysis of a Prospective Study
Masciale, V., Banchelli, F., Grisendi, G., D’Amico, R., Maiorana, A., Stefani, A., Morandi, U., Stella, F., Dominici, M., & Aramini, B. (2022) · Stem Cells Translational Medicine · doi:10.1093/stcltm/szac040 · Cited by 4
Adjuvant chemotherapy in patients with recurrence after completely resected stage IB lung adenocarcinoma: Propensity‐matched analysis in a cohort of 147 recurrences
Xu, F., Chen, H., Xu, H., Li, J., Hao, X., Xing, P., Ying, J., & Wang, Y. (2022) · Thoracic Cancer · doi:10.1111/1759-7714.14659 · Cited by 4
An End-to-End Integrated Clinical and CT-Based Radiomics Nomogram for Predicting Disease Severity and Need for Ventilator Support in COVID-19 Patients: A Large Multisite Retrospective Study
Vaidya, P., Alilou, M., Hiremath, A., Gupta, A. B., Bera, K., Furin, J. J., Armitage, K. B., Gilkeson, R., Yuan, L., Fu, P., et al. (2022) · Frontiers in Radiology · doi:10.3389/fradi.2022.781536 · Cited by 3
Self-citation
Bibliometric analysis of the 50 most cited articles on artificial intelligence for lung cancer imaging
Serındere, M. (2023) · Journal of Health Sciences and Medicine · doi:10.32322/jhsm.1294551 · Cited by 3
Low-Dose CT Screening of Persistent Subsolid Lung Nodules: First-Order Features in Radiomics
Yoshiyasu, N., Kojima, F., Hayashi, K., Yamada, D., & Bando, T. (2023) · The Thoracic and Cardiovascular Surgeon · doi:10.1055/a-2158-1364 · Cited by 3
Identification of a rank-based radiomic signature with individualized prognostic value for lung adenocarcinoma in a multi-cohort study
Liu, Y., Wang, Z., Yang, L., Zhang, M., Li, M., Zhang, J., Tang, L., Jiang, Z., Li, X., Deng, J., et al. (2024) · European Journal of Radiology · doi:10.1016/j.ejrad.2024.111782 · Cited by 3
Augmented Features Synergize Radiomics in Post-Operative Survival Prediction and Adjuvant Therapy Recommendation for Non-Small Cell Lung Cancer
Chan, L., Ding, T., Shao, H., Huang, M., Hui, W. F.-Y., Cho, W. C. S., Wong, S. C. C., Tong, K. W., Chiu, K. W.-H., Huang, L., et al. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.659096 · Cited by 3
Value of adjuvant chemotherapy for patients with pT2N0M0 non‐small cell lung cancer receiving radical resection
Chen, S., Yang, S., Zhao, Y., Zhang, Y., Huang, Q., Wu, H., Hu, H., Sun, Y., Zhang, Y., Xiang, J., et al. (2023) · Thoracic Cancer · doi:10.1111/1759-7714.15192 · Cited by 3
The potential and challenges of radiomics in uncovering prognostic and molecular differences in interstitial lung disease associated with systemic sclerosis
Zhang, L., Zheng, J.-L., Jin, Z., Chen, Q.-Y., Liu, S.-Y., & Zhang, B. (2022) · European Respiratory Journal · doi:10.1183/13993003.02792-2021 · Cited by 2
IDH-mutant glioma risk stratification via whole slide images: Identifying pathological feature associations
Wang, X., Wang, Z., Wang, W., Liu, Z., Ma, Z., Guo, Y., Su, D., Sun, Q., Pei, D., Duan, W., et al. (2024) · iScience · doi:10.1016/j.isci.2024.111605 · Cited by 2
Self-citation
PD-L1 expression and its association with clinicopathological and computed tomography features in surgically resected non-small cell lung cancer: a retrospective cohort study
Wang, S., Xu, M., Liu, Y., Hou, X., Gao, Z., Sun, J., & Shen, L. (2025) · Scientific Reports · doi:10.1038/s41598-025-10437-9 · Cited by 2
Development of a multi-feature predictive model for risk stratification in stage IB-IIA non-small cell lung cancer: a multicenter analysis
Zhong, X., Lin, H., Zhang, R., She, Y., Chen, X., Zhao, W., Luo, S., Liu, E., Liu, Q., Liu, J., et al. (2025) · European Journal of Radiology · doi:10.1016/j.ejrad.2025.112379 · Cited by 2
Habitat-based CT radiomics profiling spatial-temporal heterogeneity in resectable NSCLC predict pathological response to neoadjuvant chemoimmunotherapy: a multi-center study
Peng, Q., Xu, Y., Shen, L., Bao, X., Zhou, S., Ye, X., Gu, Y., & Gong, J. (2026) · npj Precision Oncology · doi:10.1038/s41698-026-01388-z · Cited by 2
A potential biomarker based on clinical-radiomics nomogram for predicting survival and adjuvant chemotherapy benefit in resected node-negative, early-stage lung adenocarcinoma
Ma, X., Lv, W., Wang, C., Tu, D., Qiao, J., Fan, C., Niu, J., Zhou, W. J., Liu, Q., & Xia, L. (2022) · Journal of Thoracic Disease · doi:10.21037/jtd-21-1520 · Cited by 2

Authors: Vaidya, P., Bera, K., Gupta, A., Wang, X., Corredor, G., Fu, P., Beig, N., Prasanna, P., Patil, P. D., Velu, P. D., Rajiah, P., Gilkeson, R., Feldman, M. D., Choi, H., Velcheti, V., & Madabhushi, A.
Affiliations: Case Western Reserve University (US)
University Hospitals of Cleveland (US)
Cleveland Clinic (US)
Weill Cornell Medicine (US)
Mayo Clinic (US)
University of Pennsylvania (US)
NYU Langone’s Laura and Isaac Perlmutter Cancer Center (US)
Louis Stokes Cleveland VA Medical Center (US)
Corresponding author: Madabhushi, Anant
ORCID: Vaidya, Pranjal
Bera, Kaustav
Gupta, Amit
Wang, Xiangxue
Corredor, Germán
Fu, Pingfu
Beig, Niha
Prasanna, Prateek
Patil, Pradnya D
Velu, Priya D
Rajiah, Prabhakar
Gilkeson, Robert
Feldman, Michael D
Choi, Humberto
Velcheti, Vamsidhar
Madabhushi, Anant
Venue: The Lancet Digital Health
Publisher: Elsevier BV
Published: 2020-03
Volume: 2
Issue: 3
Pages: e116-e128
ISSN: 2589-7500 (ISSN-L)
DOI: 10.1016/s2589-7500(20)30002-9
PMC: PMC7051021
OpenAlex: W3006347021
Cited by: 134
References: 27
Citations by year: 2026: 12 · 2025: 18 · 2024: 22 · 2023: 18 · 2022: 30 · 2021: 28 · 2020: 6
FWCI: 9.98
Type: journal article
Language: en
Open access: gold
doi.org
Licence: cc-by
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
creativecommons.org/licenses/by/4.0/ (vor)
Locations: The Lancet Digital Health (publishedVersion, cc-by)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders: U.S. Department of Defense (W81XWH-18\u20131-0440, W81XWH-18, 1-0440)
National Institutes of Health (P50CA174523, 01A1, 1U24CA199374\u201301, 1P20 CA233216\u201301, R01 CA220581\u201301A1, 1U01 CA239055\u201301, R01CA202752\u201301A1, R01CA208236\u201301A1, R01 CA216579\u201301A1)
DOD Peer Reviewed Cancer Research Program (W81XWH-16\u20131-0329, 1-0329, W81XWH-16)
National Institute of Diabetes and Digestive and Kidney Diseases (1K25 DK115904\u201301A1)
National Cancer Institute
Wallace H. Coulter Foundation
Case Western Reserve University
Dana Foundation
National Center for Research Resources (IBX004121A, 1 C06 RR12463, 1 C06 RR12463\u201301)
Government of South Australia
U.S. Department of Veterans Affairs
Topics: Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Radiomics and Machine Learning in Medical Imaging
Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Lung Cancer Diagnosis and Treatment
Health Sciences › Medicine › Oncology › Inflammatory Biomarkers in Disease Prognosis
Keywords: radiomics, non-small cell lung cancer, adjuvant chemotherapy, early-stage lung cancer, disease-free survival, nomogram, texture features, computed tomography, prognostic score, lymphovascular invasion, TNM staging, surgical resection, treatment selection, LASSO Cox regression, model validation, The Cancer Imaging Archive, Cleveland Clinic Foundation, University of Pennsylvania
MeSH terms: Aged, Carcinoma, Non-Small-Cell Lung, Female, Forecasting, Humans, Male, Middle Aged, Neoplasm Staging, Retrospective Studies, Tomography, X-Ray Computed, Chemotherapy, Adjuvant, Outcome Assessment, Health Care, Disease-Free Survival

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

CT derived radiomic score for predicting the added benefit of adjuvant chemotherapy following surgery in stage I, II resectable non-small cell lung cancer: a retrospective multicohort study for outcome prediction

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks